The University of New Mexico Cancer Center recently enrolled its first patient in a phase 3 international clinical trial to test a personalized vaccine against metastatic kidney cancer. Kidney cancer has proven particularly difficult to treat with chemotherapy, and numerous attempts to create a kidney cancer vaccine have not improved survival rates.
from The Medical News http://ift.tt/1DDgmSE
Our mission is to advice, and to make the people of the world healthier through the power of information.
No comments:
Post a Comment